Director, Grants Funding Program
NIH Office of Dietary Supplements
Bethesda, Maryland, United States
Patricia A. Haggerty, Ph.D., is Director of the Grant Funding Program in the NIH Office of Dietary Supplements (ODS). In this capacity, she manages the ODS Grant and Co-funding Program which allows ODS to promote and share the costs of dietary supplement-related research with NIH Institutes, Centers, and Offices (ICOs). She develops partnerships and collaborations with NIH ICOs on extramural research funding initiatives of high priority to the NIH and ODS. Before joining ODS in 2021, Dr. Haggerty was at the National Institute of Allergy and Infectious Diseases (NIAID), serving in the Division of Extramural Activities as Senior Advisor to the Director and Associate Director for Operations, for 13 years. Prior to NIAID, she was at the National Heart, Lung, and Blood Institute (NHLBI) and held the positions of Branch Chief in the Office of Scientific Review and Executive Secretary of the NHLBI Clinical Trials Review Committee. Dr. Haggerty’s primary research interests include nutrition systems biology, global nutrition, and the relationship of nutrition and dietary supplements to the immune system, infectious disease, and cardiovascular diseases.
Dr. Haggerty earned her Ph.D. in Human Nutrition from the London School of Hygiene and Tropical Medicine, and an M.Sc. in Nutritional Biochemistry from the Massachusetts Institute of Technology. Her graduate studies led to extensive research and field experience in maternal-child health and nutrition program policy, planning, and evaluation in lower- and middle-income countries. Dr. Haggerty worked with global entities including the U.S. Agency for International Development, the Food and Agriculture Organization, the World Health Organization, and U.S. private voluntary organizations. She has worked in over 30 countries and lived in Burkina Faso and the Democratic Republic of the Congo.
Connect with the Fed Office Hours
Sunday, June 30, 2024
11:00 AM – 12:00 PM CT
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.